Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma

Published:2012-08 Issue:8 Volume:23 Page:1943-1953
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Albiges L.,Chamming's F.,Duclos B.,Stern M.,Motzer R.J.,Ravaud A.,Camus P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/8/1943/318096/mds115.pdf

Reference64 articles.

1. Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial;Escudier;Clin Oncol,2009

2. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal-cell carcinoma;Motzer;J Clin Oncol,2009

3. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial;Sternberg;J Clin Oncol,2010

4. Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival;Escudier;J Clin Oncol,2010

5. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma;Hudes;N Engl J Med,2007

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 63/m mit Z. n. Nierentransplantation und linksseitigem Thoraxschmerz;Die Nephrologie;2024-08-06

2. Idelalisib-Induced Pneumonitis in Chronic Lymphocytic Leukemia;Cureus;2024-05-02

3. 分子標的型抗がん薬による間質性肺疾患発症の分子機構に基づく予測法の開発—mTOR阻害薬による間質性肺疾患とSTAT3の関連—;YAKUGAKU ZASSHI;2023-11-01

4. Novel therapeutic approaches for pleural mesothelioma identified by functional ex vivo drug sensitivity testing;Lung Cancer;2023-04

5. Development and safety of PI3K inhibitors in cancer;Archives of Toxicology;2023-02-11